FDA Inspection 878235 — Topiderm Inc.

Topiderm Inc. — FEI 2432734

The FDA completed an inspection of Topiderm Inc. on May 13, 2014 in Amityville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 13, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Amityville, NY (United States)

Citations

IDCFRDescription
202621 CFR 211.192Quality control unit review of records
357021 CFR 211.100(a)Approval and review of procedures
358521 CFR 211.110(a)Control procedures to monitor and validate performance